Get the Daily Brief
Latest Biotech News
AI Enhances Cancer Diagnostics and Drug Discovery
Pharmaceutical companies including AbbVie, Johnson & Johnson, Bristol Myers Squibb, Takeda, and Astex have formed a consortium to share proprietary structural data, boosting AI-powered drug...
Gene Editing and Bispecific Antibody Innovation Advance
Biotech firms continue to push the boundaries in gene editing and bispecific antibody engineering. UK-based Forge Genetics secured £2 million to develop a novel gene editing platform as an...
Breakthroughs in Neurodegenerative Disease Research
Recent studies have unveiled novel insights into neurodegenerative diseases. Researchers at the La Jolla Institute and Columbia University provided strong evidence that amyotrophic lateral...
Gene Therapy and Protein Production Innovations
Cutting-edge biotechnologies are emerging in gene therapy and protein manufacturing. Cirrus Therapeutics launched with $11 million to develop gene therapies targeting eye aging diseases by...
Cancer Therapy Developments and Biomarkers
Research progresses in novel cancer treatments and biomarker discovery. Genialis partnered with Cleveland Clinic to develop AI-assisted predictive biomarkers for pancreatic cancer therapy...
Clinical Advances in Lung Cancer Treatment and Prediction
Significant strides are being made in lung cancer care. A dynamic nomogram model was developed to predict brain metastasis risk in stage III non-small cell lung cancer patients undergoing...
FDA and Regulatory Environment Amid U.S. Government Shutdown
The ongoing U.S. federal government shutdown has significantly impacted the FDA’s regulatory functions, particularly halting acceptance of new drug and biologic submissions that require user fees....
Pfizer and Trump Strike Drug Pricing Deal: Impact on Pharma Market
Pfizer has become the first pharmaceutical company to agree to the Trump administration's most-favored nation (MFN) drug pricing plan, aligning US drug prices with those in comparable developed...
Takeda Exits Cell Therapy Research Amid Strategic Shift
Japanese pharmaceutical giant Takeda announced complete discontinuation of its cell therapy research efforts after previously scaling back its work in this space. The company plans to seek...
Genmab Acquires Merus for $8 Billion to Bolster Bispecific Antibody Pipeline
Danish biotechnology company Genmab is set to acquire clinical-stage biotech Merus in an $8 billion all-cash deal focused on accelerating growth through Merus' lead asset, petosemtamab, an...
Advanced AI and Deep Learning Enhance Cancer Diagnostics and Drug Discovery
Multiple AI-driven innovations are transforming cancer diagnostics and drug development. Notably, a collaboration involving pharmaceutical giants Abbvie, J&J, Bristol Myers Squibb, Takeda, and...
Breakthroughs in Spatial and Proteomic Technologies for Precision Health
Cutting-edge spatial omics and proteomic platforms are advancing biomarker discovery and disease characterization. The GeoMx Discovery Proteome Atlas offers high-plex protein profiling with over...
Innovative Biotechnologies Targeting Neurological and Neurodegenerative Diseases
Promising novel therapies and platforms for neurological disorders are emerging. Aerska launched with $21 million seed funding to develop RNAi drugs targeting the brain, advancing treatments for...
Single-Cell Genomics and Automation Drive Scalability in Biomedical Research
Single-cell RNA sequencing technologies are rapidly scaling up due to advances in automation and improved chemistries. Companies like SPT Labtech integrate automated liquid handling with leading...
AI and Machine Learning Revolutionize Molecular and Cellular Biology
Novel AI models and computational tools are enabling breakthroughs in molecular biology. The trimodal protein language model ProTrek integrates sequence, structure, and functional descriptions,...
Significant Advances in Cancer Research: Diagnostics and Therapeutics
Researchers worldwide are making crucial advances in cancer biology and treatment. Organoid models derived from primary and xenograft ovarian tumors show promise in predicting platinum therapy...
AI and Genomic Technologies Accelerate Proteomics and Protein Production
Recent breakthroughs in artificial intelligence and genomic technologies are revolutionizing protein research and production. New methods like ProTrek integrate multimodal protein language models...
Takeda’s Strategic Exit from Cell Therapy Shifts Focus to Novel Modalities
Japanese pharmaceutical giant Takeda has announced a complete halt to all cell therapy research and development activities as part of its strategic portfolio prioritization. After building...
Pfizer and Trump Administration Announce Drug Pricing Deal and Direct-to-Consumer Platform
Pfizer has reached an agreement with the Trump administration to offer medicines at prices comparable to those found in other developed countries, marking the first drug maker to sign on under the...
Genentech and Genmab’s Merus Acquisition Signals Bispecific Antibody Expansion
Danish biotech leader Genmab has announced an $8 billion all-cash acquisition of Merus, a clinical-stage bispecific antibody specialist well-known for petosemtamab, its lead EGFRxLGR5 bispecific...